Breast Implants

• Breast Implants - FDA

RSMo. 376.1250.5 requires “the attending physician shall advise the patient the advantages, disadvantages, and risks, including cancer, associated with breast implantation prior to such operation.”

It is suggested that you thoroughly discuss any questions or concerns with your physician and/or surgeon regarding breast implantation. For more information useful in making a decision regarding breast implantation, including potential dangers and side effects, visit the U.S. Food and Drug Administration.